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Adult T cell leukemia (ATL) is induced by an infection with human T lymphotropic virus type I (HTLV-I) and is accompanied
by immunodeficiency. Monocyte-derived immature dendritic cells (DCs) donated by 11 ATL patients were suppressed in the
ability to take up fluorescein isothiocyanate (FITC)–dextran and were down-regulated in the expression of CD1a and CD86
antigens (Ags). Monocytes from the patients showed impaired expression of CD14 and HLA-DR Ags. These results suggest
intrinsic abnormalities of monocytes and a defect of DC maturation in ATL patients. Therefore, we examined the influence
of HTLV-I infection of monocytes on their differentiation to DCs. Monocytes obtained from healthy donors were susceptible
to HTLV-I infection in vitro. HTLV-I-infected monocytes were down-regulated in the expression of CD14 Ags, and immature
DCs obtained from them expressed CD1a poorly and were impaired in the ability to take up FITC–dextran. Mature DCs
differentiated from these cells could not stimulate autologous CD41 T cell or CD81 T cell proliferation, even after being
secondarily pulsed with HTLV-I at an immature DC stage. These results suggest that HTLV-I-infected monocytes cannot
properly differentiate to DCs and that this might be one of the important mechanisms producing dysfunctional DCs in ATL
patients. © 2000 Academic Press
cINTRODUCTION
Adult T cell leukemia (ATL) develops 40–60 years after
infection with human T lymphotropic virus type I (HTLV-I)
in the newborn period (Takatsuki et al., 1977; Uchiyama
t al., 1977). During the asymptomatic period of more
han 40 years, B cells produce anti-HTLV-I antibodies
Abs), but cytotoxic T lymphocytes (CTL) are considered
o control mainly the outgrowth of HTLV-I-infected cells
nd the expansion of ATL cells. Once ATL develops, both
D41 and CD81 T cells show a defect in the proliferative
esponse to various stimuli and it is hard to induce CTL
hat is specific to HTLV-I Ags in vitro, although there are
eports of successfully generating CTL from a few ATL
atients (Kannagi et al., 1983, 1991). Therefore, the un-
ontrollable expansion of leukemic T cells and the re-
ulting ATL manifestation seem highly associated with
he functional deficiency of lymphocytes including HTLV-
-specific CTL. Among the important mechanisms lead-
ng to development of immunodeficiency, the production
f functionally impaired antigen-presenting cells (APCs)
uch as dendritic cells (DCs) or lack of production of
roper APCs seems to play an important role. DCs are
he most potent APC in that they can stimulate naive and
emory CD41 and CD81 T cells (Inaba et al., 1987, 1990).
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140The DCs are functionally divided into two major groups.
One group includes immature DCs that localize in the
blood and peripheral organs and show a distinct ability
to internalize various antigens (Ags) through macropino-
cytosis and the mannose receptor pathway and to pro-
cess them (Reis e Sousa et al., 1993; Sallusto et al.,
1995). In contrast to the immature DCs, mature DCs
ensure a strong ability to prime and stimulate T cells
specific to an Ag and to allogenic major histocompatibil-
ity complex (MHC) molecules. The maturation of DCs is
induced by the exposure of immature DCs to inflamma-
tory cytokines such as interleukin-1 (IL-1), IL-6, and tu-
mor necrosis factor-a (TNF-a) and by cell-to-cell contact
with activated T cells through CD40 ligand molecules
expressed on them (O’Doherty et al., 1993; Roake et al.,
1995). However, in the presence of some cytokines such
as IL-10, DC maturation is suppressed (Enk et al., 1993;
Steinbrink et al., 1997).
In addition to ATL, HTLV-I induces an inflammatory
neurogenic disease, HTLV-I-associated myelopathy/trop-
ical spastic paraparesis (HAM/TSP), in which CD41 T
ells as well as CD81 T cells are highly activated in an
APC-dependent fashion (Osame et al., 1986; Hollsberg
and Hafler, 1993). In a previous report, we showed that
monocyte-derived DCs were susceptible to HTLV-I infec-
tion in vitro and in vivo in HAM/TSP patients (Makino etl., 1999). The virus-infected DCs stimulate autologous
nprimed CD41 and CD81 T cells that may be associ-
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141DENDRITIC CELLS FROM HTLV-I-INFECTED MONOCYTESated with the development of HAM/TSP (Makino et al.,
1999). In contrast to this inflammatory disease, DCs ob-
tained from tumor-bearing animals are reported to be
functionally defective (Chaux et al., 1997; Ishida et al.,
998). In this study, we examined DCs obtained from ATL
atients and found that functions of ATL patients’ DCs
ad deteriorated. Furthermore, it has been reported that
onocytes are susceptible to HTLV-I infection in vitro
nd in vivo in ATL patients (Koyanagi et al., 1993; Waka-
matsu et al., 1999). Therefore, we assessed DCs differ-
entiated from peripheral monocytes that were infected
with HTLV-I in vitro to clarify the immunological mecha-
nisms leading to production of immunocompromised
DCs.
RESULTS
Characteristics of DCs obtained from ATL patients
Monocyte-derived DCs were successfully produced
from 10 healthy individuals and from 8 patients among
the 11 ATL patients examined, although the production
rate of DCs from monocytes was reduced in the patients
compared to that of normal controls [the DC production
rate from CD22 peripheral blood mononuclear cells (PB-
MCs): 2.6 6 1.1% (ATL, n 5 11) vs 9.8 6 2.7 (control, n 5
0), P , 0.01]. Among the healthy controls, there was
ittle variation in all the parameters examined; therefore,
e presented only a representative normal donor. The
PC function of mature DCs was assessed by using
llogeneic mixed lymphocyte reactions (MLRs) (Fig. 1a).
e tested two different doses of mature DCs as a stim-
lator and obtained a similar result. Among the 3 patients
xamined, one patient’s DCs did not stimulate allogeneic
nseparated T cells, CD41 T cells, or CD81 T cells as
trongly as DCs from a normal donor. However, the
econd patient’s DCs showed a reduced ability to stim-
late solely CD41 T cells and the third patient produced
Cs that stimulated the T cells to almost the same extent
s with a normal donor’s DCs. The phenotypic features of
he mature DCs from ATL patients were examined (Fig.
b). All of the DCs expressed CD83 Ags, a marker of
ature DCs; however, the expression level of human
istocompatibility leukocyte Ag (HLA)-ABC molecules
as reduced compared to DCs from a normal donor.
owever, no substantial differences were found in the
xpression of HLA-DR, CD40, or CD86 Ags between
ormal controls and ATL patients (Fig. 1b). In contrast to
ature DCs, there were statistically significant differ-
nces between normal controls and the patients (Fig. 2).
hile immature DCs from ATL patients expressed no
TLV-Igag Ags in contrast to DCs from HAM/TSP pa-
ients (Makino et al., 1999) and expressed HLA-ABC Ags
imilarly to the DCs from the normal donor, the expres-
ion level of CD1a and CD86 Ags was consistently re-
uced and the level of fluorescein isothiocyanate (FITC)–
extran uptake was down-regulated in the patients’ DCs pFig. 2). We did not test viral infection to DCs from pa-
ients by polymerase chain reaction (PCR) because both
BMCs and T cells from the ATL patients were actually
ound to be infected with HTLV-I by PCR analysis (not
hown) and possible contamination of a small number of
uch infected cells made it extremely difficult to deter-
ine viral infection to DCs.
henotypic features of precursor monocytes from
TL patients
FIG. 1. (a) Allogeneic mixed DC-T cell reactions. Mature DCs were
obtained from an uninfected representative normal donor and three
ATL patients and were used as stimulator (5 3 103/well). Unseparated
D41 or CD81 T cells (1 3 105/well) from a normal donor were used as
esponders. A 5-day proliferation assay was done in triplicate, and the
ean 6 SD is shown. (b) Expression of various molecules on mono-
cyte-derived mature DCs obtained from a healthy donor and ATL
patients. (- - -) Control mAb; (—) indicated mAb. The number in each
figure represents the mean fluorescence intensity. There were no
statistical differences between ATL patients and normal controls in all
parameters examined.The defects found in the immature DCs from ATL
atients might be due to abnormalities of precursor
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142 MAKINO ET AL.monocytes. We cultured PBMCs for 60 min after deple-
tion of CD21 T cells and obtained freshly adhering cells.
Among the freshly adhered cells, 9.3 6 1.6% cells from a
normal donor expressed CD14 molecules; however, the
cells from ATL patients did not express the CD14 Ags as
strongly as those from a normal donor (P , 0.05 in the
ean fluorescence intensity) (Fig. 3). Almost all CD14
olecules on the patients’ cells seemed to be masked,
ecause when the cells were cultured for 5 days, they
xpressed CD14 molecules. However, the expression
evels of HLA-DR molecules on the cultured cells from
TL patients were lower than those from the normal
onor (Fig. 3, P , 0.01 in the mean fluorescence inten-
ity).
nfluence of HTLV-I infection on monocytes from
ormal donors
To clarify the mechanisms leading to the abnormalities
ound in ATL patients, we examined the effect of HTLV-I
nfection on monocytes. Monocytes from a normal donor
ere pulsed with twenty 50% cell culture infective doses
CCID50) of cell-free HTLV-I and cultured for 5 days. Using
rimers corresponding to the HTLV-Igag or px regions,
roviral DNA was detectable as a faint signal by PCR (not
hown) and as a strong band by nested PCR from day 1
o day 5 after infection (Fig. 4a). The proviral DNA was
till detectable after treatment with RNase (not shown).
he viral infection of monocytes from a normal donor
nduced phenotypic changes in them (Fig. 4b). Mono-
FIG. 2. Expression of HTLV-I Ags and various molecules and the level
of FITC–dextran taken up by immature DCs. The immature DCs from
healthy donors and ATL patients were differentiated by using rGM-CSF
and rIL-4 for 4 days. A representative normal donor is shown. (- - -)
Control mAb; (—) indicated mAb or FITC–dextran. The number in each
figure represents the mean fluorescence intensity (mean 6 SD was
calculated from three healthy donors). Statistically significant differ-
ences between normal individuals and ATL patients were calculated by
using Student’s t test.ytes infected by using cell-free HTLV-I or by cell-to-cell
ontact with MT-2 cells expressed HTLV-Igag Ags andad a reduced level of CD14 molecules on their surface
t day 5 of culture compared to monocytes pulsed with
ontrols (inactivated virus or Jurkat cells) (Fig. 4b).
LA-DR Ag expression was not influenced by the virus
nfection (Fig. 4b).
bnormalities of DCs differentiated from HTLV-I-
nfected monocytes
To examine the influence of viral infection on normal
onor-derived monocytes in terms of DC differentiation,
mmature and mature DCs were differentiated from
TLV-I-infected monocytes. Genomic DNA from both im-
ature and mature DCs from virus-infected monocytes
ontained an HTLV-I proviral DNA detectable as a faint
and by primary PCR (not shown) and as a strong band
y nested PCR (Fig. 5a). Phenotypically the expression of
D1a molecules on the immature DCs from monocytes
nfected by using cell-free virus or MT-2 cells was down-
egulated compared to those from control Ag-pulsed
onocytes and the expression of CD86 Ag was reduced
hen immature DCs were differentiated from monocytes
nfected by cell-to-cell contact with MT-2 cells (Fig. 5b).
he level to take up FITC–dextran was reduced in imma-
ure DCs from monocytes infected by using both viral
FIG. 3. Expression of CD14 and HLA-DR Ags on fresh plastic adher-
ent and cultured monocytes. Monocytes were obtained from three
healthy donors and ATL patients. Plastic adherent monocytes were
obtained by culturing CD2 depleted PBMCs for 60 min and were
removed with a cell scraper. The adherent monocytes were cultured for
5 days in the presence of 20% fetal calf serum. (- - -) Control mAb; (—)
indicated mAb. The percentage represents the percentage of positive
cells and the numbers in parentheses and the numbers in each panel
for cultured monocytes represent mean fluorescence intensity. Mean 6
SD was calculated from three healthy donors, and statistically signifi-
cant differences between normal individuals and ATL patients in the
mean fluorescence intensity were calculated by using Students’ t test.
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143DENDRITIC CELLS FROM HTLV-I-INFECTED MONOCYTESsources (Fig. 5b). However, the phenotype of mature DCs
from virus-infected monocytes was not affected in the
expression of molecules including CD40, CD86, and
HLA-DR Ags (not shown). In contrast to these phenotypic
features, the autologous T cell-stimulating function of
mature DCs obtained from the virus-infected monocytes
was affected. Mature DCs infected with HTLV-I at a stage
of immature DCs, but not at day 0 of the monocyte stage,
strongly stimulated autologous CD41 T cells and CD81 T
FIG. 4. (a) Detection of HTLV-I proviral DNA by nested PCR. Plastic
adherent monocytes from healthy donors were pulsed with 20 CCID50
of cell-free HTLV-I or an equivalent dose of heat-inactivated virus and
cultured for 5 days. Genomic DNA was extracted from mock- or HTLV-
I-infected monocytes on days 1, 3, and 5 after culture and amplified by
PCR. (b) Expression of various molecules on cultured monocytes.
Monocytes were obtained from a healthy donor and the same mono-
cyte population was pulsed with indicated Ags and cultured for 5 days.
Twenty CCID50 of HTLV-I and/or the equivalent dose of heat-inactivated
irus and 2 3 105 cells/well of Jurkat or MT-2 cells were used as
ntigens. A representative of three independent experiment is shown.cells as described previously (Makino et al., 1999); how-
ever, mature DCs differentiated from HTLV-I-infected
f
bmonocytes did not stimulate autologous T cells despite
being infected with the virus (not shown). Various
amounts of virus (up to 100 CCID50 cell-free virus or 8 3
05 MT-2 cells) were pulsed to monocytes, but mature
DCs differentiated from them did not stimulate autolo-
FIG. 5. (a) Detection of HTLV-I proviral DNA by nested PCR. Immature
and mature DCs were generated from mock- or HTLV-I-infected mono-
cytes. Monocytes were obtained from healthy donors and pulsed with
20 CCID50 of HTLV-I or an equivalent dose of heat-inactivated virus.
enomic DNA was extracted from mock- or HTLV-I-infected immature
r mature DCs and amplified by PCR. Lane 1: size marker. Lanes 2–5:
mmature DCs. Lane 2: case 1, mock-infected. Lane 3: case 1, HTLV-I-
nfected. Lane 4: case 2, mock-infected. Lane 5: case 2, HTLV-I-in-
ected. Lanes 6–9: mature DCs. Lane 6: case 1, mock-infected. Lane 7:
ase 1, HTLV-I-infected. Lane 8: case 2, mock-infected. Lane 9: case 2,
TLV-I-infected. Lane 10: positive control. (b) Expression of various
olecules and uptake of FITC–dextran by immature DCs generated
rom HTLV-I-infected monocytes. Monocytes were obtained from a
ealthy donor and pulsed with Ags. Twenty CCID50 of HTLV-I or an
equivalent dose of heat-inactivated virus and 2 3 105 cells/well of
urkat or MT-2 cells were used as Ags. Immature DCs were generated
rom the Ag-pulsed monocytes by using rGM-CSF and rIL-4. The num-
er in each panel represents the mean fluorescence intensity.
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144 MAKINO ET AL.gous T cells (not shown). In order to confirm the lack of
APC function of DC from virus-infected monocytes, im-
mature DCs from virus-infected monocytes were second-
arily pulsed with cell-free HTLV-I on day 5 (Table 1).
Positive control DCs (nonpulsed at the monocyte stage
and pulsed at the immature DC stage with the cell-free
virus) induced strong proliferation of T cells, and DCs
from monocytes pulsed with inactivated virus or Jurkat
cells on day 0 and secondarily pulsed with the HTLV-I at
an immature DC stage induced almost the same level of
proliferation of CD41 T cells and CD81 T cells, although
the proliferation level of unseparated T cells seemed
slightly reduced compared with that of positive control
DCs. However, mature DCs differentiated from virus-
infected monocytes did not stimulate unseparated T
cells, CD41 T cells, or CD81 T cells, even when doubly
infected with HTLV-I on day 5. There were statistical
differences in the ability to stimulate T cells between
DCs from monocytes pulsed with controls and those
from HTLV-I-infected monocytes (Table 1). To test a dif-
ferent viral source, we established an HTLV-I-infected T
cell line from a HAM/TSP patient and examined its influ-
ence on monocytes. Mature DCs generated from mono-
cytes pulsed with the cells themselves or with cell-free
virus obtained from them showed similar dysfunction
(not shown).
Influence of HTLV-I infection of monocytes from
healthy donors on IL-10 production
Since monocytes are known to produce IL-10 by vari-
ous stimuli, we examined IL-10 production from mono-
cytes that were donated by healthy donors and were
infected with HTLV-I in vitro (Table 2). As a positive
T
Autologous T Cell Proliferative Responses to DCs from Monocyte
Antigen
Day 0
(Monocyte)
Day 5
(Immature DC) Unse
None None 1
Inactivated virus Live virus 2
Live virus Live virus
Jurkat Live virus 5
MT-2 Live virus 1
None Live virus 8
a The responder T cells (1 3 105/cell) were stimulated for 5 days w
ealthy donor. Monocytes were infected or remained uninfected on da
state. The monocytes were infected by using 20 CCID50 of cell-free HT
heat-inactivated HTLV-I or Jurkat cells was used. Representative results
the mean 6 SD is shown. Statistically significant differences were ca
* P , 0.01.
** P , 0.001.ontrol, lipopolysaccharide (LPS) stimulation was used
nd the LPS-stimulated monocytes produced a high levelf IL-10 24 h after stimulation. Monocytes infected with
TLV-I or pulsed with control Ags produced the cytokine
n day 1; however, HTLV-I-infected monocytes secreted
significantly larger amount of IL-10 on day 3 after
timulation (20 CCID50 cell-free virus and MT-2 cells;
able 2) than control Ag-pulsed monocytes. It might be
mportant to determine whether IL-10 was exclusively
ted at Day 0 and Repulsed at Day 5 of the Immature DC Stagea
Responder ([3H]thymidine uptake; 103 cpm)
d T cells CD41 T cells CD81 T cells
.7 16.7 6 1.0 14.0 6 1.1
.9
*
49.7 6 1.9 34.2 6 2.3
.7 3.3 6 0.6 4.4 6 0.5
.0
*
49.3 6 2.2 30.3 6 1.9
.8 13.0 6 3.1 6.4 6 1.2
.6 42.9 6 2.8 45.4 6 2.6
logous monocyte-derived mature DCs (5 3 103/well) obtained from a
were re-pulsed with HTLV-I (20 CCID50) at day 5 of the immature DC
with 2 3 105/well of MT-2 cells. As a control, an identical amount of
e separate experiments are shown. Assays were done in triplicate, and
by using Student’s t test.
]
]
]
]
]
]
**
*
**
**
TABLE 2
Production of IL-10 by HTLV-I-Infected Monocytesa
Cell Stimulation
IL-10 (pg/ml)
Day 1 Day 3
Monocytes None 20.9 6 6.3 8.9 6 1.8
Monocytes LPS 10 ng/ml 728.2 6 3.5 92.0 6 3.5
Monocytes
Inactivated
HTLV-I 10 CCID50 273.3 6 27.3 50.8 6 3.3
20 CCID50 190.2 6 25.0 37.3 6 0.8
Monocytes Live HTLV-I 10 CCID50 172.4 6 6.9 72.9 6 8.3
20 CCID50 178.2 6 9.7 71.8 6 2.6
Monocytes Jurkat 0.3 3 105 99.6 6 14.5 30.0 6 5.1
1.0 3 105 197.3 6 14.7 32.7 6 2.4
MT-2 0.3 3 105 395.5 6 29.4 83.5 6 14.5
1.0 3 105 579.0 6 10.7 85.3 6 3.8
Jurkat None 0 0
MT-2 None 2.1 6 0.6 1.4 6 0.9
a Purified monocytes were obtained from a healthy donor, and IL-10
ecreted into the supernatant of monocytes (5 3 106/ml) cultured in the
presence of various Ags was measured. The supernatant was har-
vested on days 1 and 3 after the culture. Representative results of three
separate experiments are shown. Assays were done in triplicate, and
the mean 6 SD is shown. Statistically significant differences were
alculated by using Student’s t test.
*ABLE 1
s Infec
parate
0.3 6 0
8.3 6 0
5.9 6 0
6.5 6 7
2.0 6 0
4.7 6 5
ith auto
y 0 and
LV-I or
of thre
lculated* P , 0.01.
** P , 0.05.
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145DENDRITIC CELLS FROM HTLV-I-INFECTED MONOCYTESproduced by HTLV-I-infected monocytes. However, we
could not discriminate viral-infected monocytes from
control Ag-pulsed monocytes at the single-cell level.
DISCUSSION
In this study, we successfully differentiated monocyte-
derived DCs from approximately 70% of acute-type ATL
patients; however, the production rate of DCs from pa-
tients’ monocytes was reduced (not shown), allowing us
to conduct only selected, but not full, experiments. Pre-
viously we showed that the DCs from HAM/TSP patients
rapidly differentiated to both immature and mature DCs
and extensively stimulated autologous CD41 and CD81 T
ells in vitro (Makino et al., 1999). In contrast to the DCs
rom HAM/TSP patients, the expression of CD1a and
D86 Ags and the internalization activity of exogenous
gs through the mannose receptor were deteriorated in
mmature DCs obtained from ATL patients. The APC
unction of mature DCs from ATL patients was deter-
ined by using allogeneic MLR because of immunode-
iciency of patients’ T cells (Uchiyama et al., 1977). The
llogeneic stimulus is strong in general, and the T cell
roliferation response might be less affected by changes
n the DC phenotype (Takahashi et al., 1998). Therefore,
the APC function of patients’ mature DCs could not be
evaluated correctly in this study. However, elevated stim-
ulating activity as seen in HAM/TSP patients was not
observed in the least; rather the expression of CD40,
CD86, or MHC class II Ags was reduced depending on
the case (Fig. 1b). Generally, functional deficiency of DCs
was observed in tumor-bearing animal models (Chaux et
al., 1997; Ishida et al., 1998). In these mice, monocytes
could not differentiate properly to DCs and, in some
cases, some cytokines or factors have been reported to
induce the defect of their maturation (Allavena et al.,
1998; Caux et al., 1994; Ishida et al., 1998; Macatonia et
al., 1993). It has not been apparent whether functional
abnormalities of DCs observed in ATL patients are in-
duced primarily by HTLV-I infection or secondarily by
HTLV-I-infected activated T cells. However, monocytes
are known to be susceptible to HTLV-I infection in vitro
and in vivo (Koyanagi et al., 1993; Wakamatsu et al., 1999)
and monocytes from ATL patients were more strongly
down-regulated in CD14 Ag expression after adhesion to
plastic in the absence of T cells. Furthermore, no DCs
were produced in around 30% of the patients examined
(3/11). Therefore, it is possible that the maturation defect
of DCs occurs in ATL patients as in tumor-bearing ani-
mals. In order to clarify this point, we tried to differentiate
DCs from HTLV-I-infected monocytes.
The monocytes donated from healthy individuals were
easily infected with HTLV-I in vitro as evidenced by sur-
face expression of HTLV-Igag Ags and detection of pro-
viral DNA from day 1 to day 5 after infection. Interestingly
the in vitro infected monocytes were down-regulated in
a
mthe expression of CD14 molecules. The lack of CD14
expression is reported to be closely associated with
induction of apoptotic cell death of monocytes (Devitt et
al., 1998; Heidenreich et al., 1997). However, despite
incompetent CD14 expression, HTLV-I-infected mono-
cytes convincingly stimulated allogeneic T cells, ex-
pressed receptors for GM-CSF and IL-4, and differenti-
ated into DCs without showing apoptosis (not shown).
We could not determine quantitatively the proviral copy
number in DCs differentiated from HTLV-I-infected mono-
cytes because of nested PCR. Furthermore, the viral
infection rate of the DCs seemed to be very low because
the intensity of bands from the DCs was obviously lower
than that from an identical number of TL-Om1 cells,
which carry a single proviral DNA copy. Immature DCs
generated from the virus-infected monocytes were, how-
ever, moderately suppressed in the expression of CD1a
Ag and in the internalization activity of FITC–dextran.
Therefore, although more detailed functional analyses of
immature DCs remain to be conducted by using supe-
rantigens and intracellular pathogens, the most impor-
tant function of the immature DCs seems to be at least
deteriorated. Mature DCs are able to stimulate Ag-spe-
cific T cells. Their T-cell-stimulating function has been
reported to be associated with high-level expression of
MHC, adhesion, and costimulatory molecules (Sallusto
and Lanzaveccia, 1994; Scheinecker et al., 1998; Young
and Inaba, 1996). Although DCs generated from HTLV-I-
infected monocytes rather competently expressed those
molecules (Fig. 1b) and were infected with HTLV-I, they
could not stimulate autologous T cells. This point was
confirmed by double-pulse experiments. Mature DCs
generated after being doubly infected on day 0 in the
monocyte stage and on day 5 in the immature DC stage
still did not stimulate autologous CD41 T cells or CD81 T
ells. In addition to the MHC, adhesion, and costimula-
ory molecules, it has been reported that molecules on
Cs such as a C-C chemokine termed DC-CK1 (Adema
t al., 1997) and a receptor for activator of NF-kB (RANK)
Anderson et al., 1997) play important roles in conduction
f APC function. Further work will be required to clarify
he relationship between these molecules and the HTLV-
-infected monocyte-derived DCs. However, aside from
hese molecules, the failure of doubly pulsed DCs to
timulate autologous T cells might be simply due to
educed internalization activity at the immature stage.
In addition to T-cell-stimulating DCs, tolerogenic DCs
re known (Finkelman et al., 1996; Steptoe and Thom-
on, 1996). It might be possible that DCs generated from
irus-infected monocytes acted tolerogenically. The
olerogenic DCs have been produced by various exper-
mental procedures, and they induce T cell tolerance
gainst the exposed Ag (Ruedl and Hubele, 1997; Viney
t al., 1998). However, in general, these DCs are remark-
bly down-regulated in the expression of costimulatory
olecules such as CD80 and CD86. In this respect, the
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146 MAKINO ET AL.mature DCs generated by HTLV-I-infected monocytes, in
which the expression of CD86 Ags was not reduced,
seem phenotypically different from the tolerogenic DCs
(not shown).
In many tumor-bearing animal models, the functional
deficiency of DCs was observed. In these animals, mat-
uration defects are commonly observed and IL-10 and
vascular endothelial growth factor (VEGF) are reported to
be some of their important inducers (Allavena et al., 1998;
Caux et al., 1994; Gabriovich et al., 1996; Heidenreich et
al., 1997; Ishida et al., 1998). Although we could not
assess the role of VEGF, prolonged production of IL-10 by
HTLV-I-infected monocytes was observed. In particular,
IL-10 is reported to exhibit DC inhibition activity at a
relatively late stage of DC maturation (Ishida et al., 1998).
herefore, the significantly higher production of the cy-
okine at day 3 of culture of infected monocytes might be
ssociated with the maturation defects and production of
ysfunctional DCs.
It is extremely important to decide whether the func-
ional defect of DC observed in this study is induced
rimarily, that is, preceding abnormal T cell expansion, or
nduced secondarily due to T cell leukemogenesis, es-
ecially since we would like to develop an immunother-
peutic strategy against ATL. However, in ATL patients,
oth DC dysfunction and T cell abnormalities were com-
only observed. Therefore it is not easy to address this
mportant point by studies using PBMCs from ATL pa-
ients, but the functional analyses on PBMCs from
symptomatic carriers will be helpful in finding an an-
wer to this question.
In conclusion, DCs obtained from HTLV-I-infected
onocytes did not fully take up exogenous Ags and did
ot stimulate autologous T cells. Therefore, they might
e closely associated with the development of immuno-
eficiency. Although DCs obtained from ATL patients
ere not identical to the HTLV-I-infected monocyte-de-
ived DCs, especially in terms of phenotypic character-
stics, the latter type of DC could be a potent model
apable of at least partially clarifying the immunological
echanism leading to DC deficiency in ATL patients.
MATERIALS AND METHODS
tudy subjects and cell preparation
PBMCs were donated under informed consent by 11
atients diagnosed as acute-type ATL at Kagoshima Uni-
ersity Hospital and by 10 uninfected healthy individuals.
he ATL patients were not undergoing treatment with
ny immunosuppressants or glucocorticoid steroid hor-
ones. The PBMCs were isolated from heparinized
lood by using Ficoll–Paque (Pharmacia, Uppsala, Swe-
en) and were cryopreserved in liquid nitrogen until
sed as described (Makino and Baba, 1997). Plastic-
dherent monocytes were isolated from either freshly
solated or cryopreserved PBMCs, and DCs were differ-
u
1entiated by culturing them with 1% autologous plasma for
5 days in the presence of 50 ng of recombinant (r)GM-
CSF (donated by Kirin Brewery Co., Tokyo, Japan) and 10
ng of rIL-4 (Genzyme, Cambridge, MA) per milliliter. rGM-
CSF and rIL-4 were supplied every 2 days as described
previously (Makino and Baba, 1997). On day 0 of mono-
cyte culture, they were pulsed with cell-free HTLV-I, heat-
inactivated (56°C for 30 min) virus, a HTLV-I-producing
cell line MT-2, or a control lymphoma cell line, Jurkat.
Before being pulsed, both MT-2 and Jurkat cells were
treated with 200 mg/ml of mitomycin C for 30 min at 37°C.
In some cases, immature DCs were pulsed with the
cell-free HTLV-I on day 5 of cell culture. Maturation of
DCs was accomplished by treating them with 10 ng of
LPS (Escherichia coli 0111: B4, Difco Laboratories, De-
troit, MI) per milliliter for 24 h and mature DCs were
assessed for APC function after treatment with 50 mg/ml
of mitomycin C. The mitomycin C-treated MT-2 and Jurkat
cells were removed from live DC populations by using
30–55% gradient Percoll solutions. Less than 3% of MT-2
or Jurkat cells might be contaminated in the DC popula-
tion. DCs were also generated from peripheral mono-
cytes of ATL patients. In this case, the contamination of
the monocyte population with HTLV-I-infected cells was
avoided by removing CD21 T cells from PBMCs in ad-
vance by using immunomagnetic beads coated with anti-
CD2 monoclonal Abs (mAbs) (Dynabeads 450, Dynal,
Oslo, Norway), and subsequently monocytes were pre-
pared and DCs were differentiated. More than 98% of the
CD21 T cells were depleted from PBMCs. The concen-
ration of IL-10 secreted into culture supernatant fluids of
PS-stimulated or Ag-pulsed monocytes (5 3 106/ml)
was measured by using an ELISA kit (Genzyme Diagnos-
tic, Cambridge, MA) according to the method described
by Foey et al. (1998).
Preparation of cell-free HTLV-I virions and virus-
producing cell line
An HTLV-I-producing cell line, MT-2, was generously
given to us by Dr. I. Miyoshi, Kochi Medical School, and
cell-free HTLV-I virions were prepared by sonicating 5 3
106 MT-2 cells per milliliter for 50 s. Both virions released
nto the supernatant from the sonicated MT-2 cells and
T-2 cells themselves were used as a viral source. For
etection of HTLV-I proviral DNA, DNA was prepared
rom monocytes, DCs, or CD41 T cells by using a DNA
xtractor kit (Wako Pure Chemical Industries, Ltd.,
saka, Japan). The DNA was amplified by PCR using
rimer pairs corresponding to nucleotides 1729 to 1750
nd 1942 to 1964 of the HTLV-Igag region or to nucleo-
ides 6496 to 6518 and 6696 to 6718 of the HTLV-Ipx
egion. When no band or only a faint band was detected
n the PCR products, nested PCR was conducted by
sing a primer pair corresponding to nucleotides 1756 to
777 and 1919 to 1940 of the HTLV-Igag region or to
f
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147DENDRITIC CELLS FROM HTLV-I-INFECTED MONOCYTESnucleotides 6509 to 6531 and 6673 to 6695 of the HTLV-
Ipx region. The HTLV-Igag and px proviral DNAs were
detected as 185- and 187-bp bands. The CCID50 of cell-
ree HTLV-I was determined by using CD41 T cells in the
resence of 2 mg/ml of phytohemagglutinin (PHA) (Difco
Laboratories, Detroit, MI) and 100 U/ml of rIL-2 (TGP-3,
Takeda Chemical Industries, Osaka, Japan). Monocytes
and DCs were infected with 20 CCID50 of HTLV-I. Infec-
tion of monocytes and DCs with HTLV-I was also deter-
mined by cytometry analysis (FACScan, Becton Dickin-
son Immunocytometry Systems, San Jose, CA) for sur-
face expression of HTLV-Igag Ags. In some cases, CD41
T cells obtained from uninfected donors were infected by
using MT-2 as described previously (Takamoto et al.,
1997) and were used as a viral source.
Analysis of cell surface Ag
The expression of cell surface Ag on monocytes, im-
mature DCs, and mature DCs was determined by using
FACScan. Live cells (1 3 104) were gated and analyzed.
o eliminate dead cells from analysis, propidium iodide
Sigma Chemical Co., St. Louis, MO) was used. We used
ITC-conjugated mAbs against human HLA-ABC (G46-
.6) and HLA-DR (L243, Becton Dickinson), CD40 (5C3,
harMingen, San Diego, CA), phycoerythrin-labeled
Abs to CD54 (HA58), CD58 (L304.4) (Becton Dickinson),
D86 (IT2.2, PharMingen), and CD83 (HB15a, Immuno-
ech), and purified murine mAbs to CD1a (NA1/34, Sero-
ec Ltd., Oxford, England), HTLV-Igag (GIN14), and HTLV-
env (F10) (generously given to us by Dr. Y. Tanaka,
epartment of Hygiene, Kitazato University, Sagamihara,
apan), which were followed by FITC-labeled goat F(ab9)2
anti-mouse immunoglobulins (Igs) (Tagoimmunologicals,
Camarillo, CA). The optimal concentrations of mAbs
were determined in advance. Monocytes and DCs under
an apoptotic process were determined by staining them
with FITC-conjugated Annexin V (Genzyme). The ability of
immature DCs to internalize FITC–dextran (MW 42,000,
Sigma) through a mannose receptor was tested. In brief,
DCs were harvested and resuspended at 106 cells per
milliliter in RPMI medium supplemented with 10% fetal
calf serum (FCS) and HEPES (pH 7.4). Two hundred
microliters of DC suspension was preincubated for 3 min
at 37°C and 20 ml of a 1 mg/ml FITC–dextran solution
as added. At 30 min of incubation, the reaction was
topped by addition of 4 ml of cold PBS supplemented
ith 0.2% bovine serum albumin, 0.01% NaN3, and 2 mM
EDTA, and the cells were washed four times at 4°C in the
same buffer. The uptake of FITC–dextran by propidium
iodide-gated viable cells was analyzed using FACScan.
Proliferation assay
Autologous and/or allogeneic DC-T cell mixed lympho-
cyte cultures were conducted by using DCs from ATL
patients and those differentiated from HTLV-I-infectedmonocytes. The DCs were harvested on day 7 of HTLV-I
infection as stimulator cells. Unseparated T cells, puri-
fied CD41 T cells, or CD81 T cells were used as a
responder population. DCs that were unpulsed, infected
by using cell-free HTLV-I or MT-2 cells, or pulsed with
heat-inactivated HTLV-I Ag or Jurkat cells were treated
with mitomycin C and plated to give a DC to responder
cell ratio of 20 or 40. Proliferation of stimulator cells was
confirmed to be completely blocked by mitomycin C. The
responder T cells were purified as follows: freshly
thawed PBMCs were depleted of MHC class II1 cells by
using magnetic beads coated with mAbs to MHC class II
Ags (Dynabeads 450, Dynal) and further treated with
beads coated with either CD4 or CD8 mAbs to select T
cells negatively. The purity of CD41 T cells or CD81 T
ells was more than 98% and the contamination of the
urified population by HLA-DR-positive cells was less
han 2%. Responder cells (1 3 105 per well) were plated
in 96-well round-bottom tissue culture plates. The cell
proliferation during the last 16 h of a 5- to 6-day culture
in the presence of 10% heat-inactivated human serum (a
generous gift from the Kagoshima Red Cross Blood Cen-
ter) was quantified by incubating the cells with 1 mCi/
ell of [3H]thymidine. The results are expressed as the
ean difference in counts per minute obtained from
riplicate cultures.
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